|
|
viii | |
Foreword |
|
xii | |
Preface to the Third Edition |
|
xiv | |
|
I INTRODUCTION TO THE DISEASE PROCESS |
|
|
|
Definitions and diagnostic criteria |
|
|
3 | (12) |
|
|
Pathophysiology: a neurochemical perspective |
|
|
15 | (12) |
|
|
|
|
Pathophysiology: an epidemiological perspective |
|
|
27 | (12) |
|
|
|
|
Typical clinical features |
|
|
39 | (14) |
|
|
|
Differentiation from non-Alzheimer dementia |
|
|
53 | (14) |
|
|
Neuropsychological assessment |
|
|
67 | (14) |
|
|
|
|
|
|
81 | (16) |
|
|
|
|
|
97 | (14) |
|
|
Electrophysiological tests |
|
|
111 | (14) |
|
|
|
125 | (12) |
|
|
|
|
Natural decline and prognostic factors |
|
|
137 | (12) |
|
|
|
|
Global assessment measures |
|
|
149 | (10) |
|
|
|
Depressive syndrome in Alzheimer's disease |
|
|
159 | (6) |
|
|
|
165 | (12) |
|
|
|
|
|
|
|
177 | (12) |
|
|
|
189 | (16) |
|
|
|
|
|
Mild cognitive impairment and very early stage Alzheimer's disease |
|
|
205 | (16) |
|
|
|
221 | (12) |
|
|
|
Care of patients in the severe stage of dementia |
|
|
233 | (14) |
|
|
|
|
|
247 | (10) |
|
|
Co-existent medical problems and concomitant diseases |
|
|
257 | (8) |
|
|
Management of neuropsychiatric symptoms |
|
|
265 | (14) |
|
|
V COMMUNITY AND INSTITUTIONAL MANAGEMENT |
|
|
|
Caregiver support: support of families |
|
|
279 | (20) |
|
|
|
Community-based formal support services |
|
|
299 | (16) |
|
|
VI ETHICAL AND QUALITY OF LIFE ISSUES |
|
|
|
|
315 | (10) |
|
|
|
325 | (16) |
|
|
|
|
341 | (10) |
|
|
|
Health-related quality of life measurement techniques in the management of dementia |
|
|
351 | (28) |
|
|
|
|
|
Future diagnosis and management of Alzheimer's disease |
|
|
379 | (4) |
|
|
|
Index |
|
383 | |